Related Experiment Video
Updated: Aug 23, 2025

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
Published on: April 18, 2016
Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses
Peter Deak1, Bradley Studnitzer1, Trevor Ung1
1Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.
Researchers identified a unique dendritic cell (DC) subpopulation, termed "first responders" (FRs), that exhibit heightened responses to pathogen-associated molecular patterns (PAMPs) and can be targeted to enhance vaccine efficacy.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cell (DC) activation by pathogen-associated molecular patterns (PAMPs) is crucial for adaptive immunity.
- The initial, stochastic distribution of DC responses to PAMP signaling remains poorly understood.
Purpose of the Study:
- To identify and characterize a unique DC subpopulation involved in early immune responses.
- To investigate the potential of this subpopulation for targeted vaccine development.
Main Methods:
- Isolation of a DC subpopulation via preferential phagocytosis of microparticles (MPs).
- Characterization of the subpopulation using cell surface markers and assessment of PAMP responses.
- In vivo studies to evaluate the impact of targeting this subpopulation on adaptive immune responses.
Main Results:
- A distinct DC subpopulation, termed "first responders" (FRs), was identified and isolated.
- FRs demonstrate enhanced responses to PAMPs and provide initial paracrine signaling.
- Targeting FRs modulated both antibody and T cell responses in vivo.
Conclusions:
- FRs represent a temporally controlled DC population influencing downstream adaptive immunity.
- Targeting FRs offers a novel strategy for improving vaccine design and efficacy.
More Related Videos
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014